Sympathoinhibitory signals from the gut and obesity-related hypertension

Cholecystokinin

(2013) Graham J. Dockray   Current Opinion in Endocrinology Diabetes and Obesity

Neural Mechanisms of Angiotensin II–Salt Hypertension: Implications for Therapies Targeting Neural Control of the Splanchnic Circulation

(2011) John W. Osborn et al.   CURRENT HYPERTENSION REPORTS

Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin

(2011) Guillaume de Lartigue et al.   PHYSIOLOGY & BEHAVIOR

Obesity, Sympathetic Overdrive, and Hypertension

(2010) Kamal Rahmouni   HYPERTENSION

Sympathetic Activation in Obesity

(2010) Guido Grassi et al.   HYPERTENSION

Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults

(2010) Elisabeth Lambert et al.   HYPERTENSION

Does our fat tell our brain what to do? A ‘sympathetic’ appraisal

(2010) Gregory D. Fink   JOURNAL OF PHYSIOLOGY-LONDON

Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms

(2010) Domitila A. Huber et al.   JOURNAL OF PHYSIOLOGY-LONDON

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

(2010)   LANCET

Abdominal vagal signalling: A novel role for cholecystokinin in circulatory control?

(2008) Daniela M. Sartor et al.   BRAIN RESEARCH REVIEWS

Leptin and its metabolic interactions - an update

(2008) Anubhuti et al.   DIABETES OBESITY & METABOLISM